These more sustainable additions to the Mevopur portfolio are being featured at Pharmapack Europe 2022, being held 18 and 19 May in the Paris Expo Porte de Versailles. And, because they are produced under Mevopur protocols, these polymer solutions also can help the manufacturers reduce their risk of regulatory non-compliance.” Manufactured using non-fossil feedstocks, the new Mevopur concentrates include polymers with bio-based content between 70 and 100%, as calculated to ASTM D6866 standard.

Mevopur™ Healthcare Bio-based Polymer Solutions | Healthcare Mevopur™ Healthcare Bio-based Polymer Solutions help reduce the carbon footprint of healthcare products Like all Mevopur products, Mevopur Healthcare Bio-based Polymer Solutions use raw materials pre-tested to ISO 10993-1, USP and , EP 3.1.3 / 3.1.5 (polyolefin packaging materials), USP (polyethylene) and ICH Q3D (elemental impurities).

Mevopur™ Healthcare Bio-based Polymer Solutions for Medical Devices and Pharmaceutical Packaging Manufacturers of medical devices and pharmaceutical packaging are increasingly faced with the challenge of integrating sustainability into the design of their products. As part of our commitment, we publish Avient’s Mevopur™ product policy and use limitations to assist customers in their product selection. For more detailed information on Mevopur uses and restrictions see www.avient.com/healthcare-use-limitations-mevopur-products or contact your Avient sales representative. 1.844.4AVIENT www.avient.com

Some of the raw materials that are used in Mevopur products are tested in accordance with selected parts of ISO 10993, USP. A goods receipt inspection with defined tests are mandatory for all raw materials used in Mevopur products. Release of finished products Production of Mevopur products are under controlled conditions according to a documented procedure.

https://www.avient.com/products/polymer-additives/performance-enhancement-additives/mevopur-functional-additives

Avient to highlight its range of colorants and additives for medical applications at Pharmapack 2025, including its ever-expanding Mevopur™ Healthcare Colorants and Formulations, to help accelerate the development of healthcare products and mitigate the risk of non-compliance Avient’s Mevopur™ Healthcare Colorants and Formulations, along with Mevopur™ Healthcare Functional Additives, were introduced to the market 15 years ago. Our Mevopur portfolio is constantly growing and adapting, but what remains unchanged is our commitment to helping our customers make high-quality healthcare products,” said Volker Dickfeld, Sr.

Mevopur™ Healthcare Functional Additives for Healthcare Applications Mevopur™ Healthcare Functional Additives for Pharmaceutical Packaging - Application Bulletin Mevopur™ Standard Colors for Healthcare

Mevopur™ Laser Welding Additives for Medical Devices - Application Bulletin Benefits of using Mevopur laser welding additives for medical devices Mevopur™ Colorants and Additives - Healthcare Polymer Solutions Brochure

Mevopur™ Laser Welding Additives for Medical Devices - Application Bulletin Benefits of using Mevopur laser welding additives for medical devices Mevopur™ Colorants and Additives - Healthcare Polymer Solutions Brochure

Mevopur™ Laser Welding Additives for Medical Devices - Application Bulletin Benefits of using Mevopur laser welding additives for medical devices Mevopur™ Colorants and Additives - Healthcare Polymer Solutions Brochure